Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
31.12
-1.41 (-4.33%)
At close: Feb 21, 2025, 4:00 PM
31.00
-0.12 (-0.39%)
After-hours: Feb 21, 2025, 7:48 PM EST
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $3.71 billion as of February 21, 2025. Its market cap has increased by 279.49% in one year.
Market Cap
3.71B
Enterprise Value
2.13B
1-Year Change
279.49%
Ranking
Category
Stock Price
$31.12
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $3.71B, an increase of 268.53%. That is a compound annual growth rate of 32.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.71B | 7.02% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |